Verisk Logo 40415Total revenue from continuing operations increased 8.5% in second-quarter 2014 compared with second-quarter 2013. Decision Analytics revenue from continuing operations increased 10.8% in the quarter, while Risk Assessment revenue increased 5.0%.

EBITDA from continuing operations increased 8.0% to $194.2 million for second-quarter 2014, with an EBITDA margin from continuing operations of 45.9%.  Diluted GAAP earnings per share (diluted GAAP EPS) were $0.52 for second-quarter 2014. Diluted adjusted earnings per share from continuing operations (diluted adjusted EPS from continuing operations) were $0.57 for second-quarter 2014, an increase of 7.5% compared with the same period in 2013.  Free cash flow year to date, normalized for the items discussed below, increased 4.0% to $228.1 million.

Verisk Analytics Q2 2014

Within the Decision Analytics segment, revenue from continuing operations grew 10.8% in second-quarter 2014. In the quarter, Decision Analytics revenue from continuing operations represented approximately 61.8% of total revenue from continuing operations.

Within the insurance category, revenue growth was 14.2% for the second-quarter of 2014. The increase was driven by strong growth in catastrophe modeling and loss quantification solutions.

In the financial services category, revenue from continuing operations increased 11.6% in second-quarter 2014 based on continued strong demand for our solutions partially offset by lower project-related revenue.

In the healthcare category, revenue in the second quarter grew 6.6%, driven primarily by growth in revenue and quality intelligence solutions. Revenue growth reflected continued expansion of solutions sold to existing customers.

In the specialized markets category, revenue increased 0.8% in second-quarter 2014. Environmental health and safety solutions led the growth.

Scott Stephenson, president and chief executive officer, said, “Our second-quarter revenue growth was good, driven by very strong performance in our insurance units. The outlook for our financial business remains excellent, and we continue to expect mid-teens growth for Verisk Health for the full year 2014. I am pleased with the efforts of all our people as they work to create the next generation of innovative solutions for our customers. We remain focused on driving long-term organic growth for Verisk and feel good about our asset mix, even as we continue to explore acquisitions that are a strong strategic fit.”

Source:  Verisk Analytics